Literature DB >> 29575280

Renal regeneration after acute kidney injury.

Silvia Coelho1,2, Guadalupe Cabral2, José A Lopes3, António Jacinto2.   

Abstract

Acute kidney injury is common and associated with negative renal and patient outcomes. The human kidney has a real but limited regeneration capacity. Understanding renal regeneration may allow us to manipulate this process and thus develop therapeutic weapons to improve patients' outcome. In the first part of this paper we discuss the clinical factors associated with renal recovery: baseline patient particularities, acute kidney injury characteristics and the medical approach taken in the short and long-term. In the second part, the cellular and molecular mechanisms underlying renal regeneration are explored. The immune system seems to have an important role, first promoting inflammation and then tissue healing. Other players, such as cellular senescence, mitochondrial dysfunction, renal haemodynamics and metabolic reprogramming also have a role in renal regeneration. We aim to develop a short review of renal regeneration, offering a holistic view of this process.
© 2018 Asian Pacific Society of Nephrology.

Entities:  

Keywords:  acute kidney injury; immune system; inflammation; kidney; regeneration

Mesh:

Year:  2018        PMID: 29575280     DOI: 10.1111/nep.13256

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  10 in total

1.  Selective EZH2 inhibitor zld1039 alleviates inflammation in cisplatin-induced acute kidney injury partially by enhancing RKIP and suppressing NF-κB p65 pathway.

Authors:  Li Wen; Shao-Hua Tao; Fan Guo; Ling-Zhi Li; Hong-Liu Yang; Yan Liang; Li-Dan Zhang; Liang Ma; Ping Fu
Journal:  Acta Pharmacol Sin       Date:  2021-12-22       Impact factor: 7.169

2.  Machine learning for the prediction of acute kidney injury in patients with sepsis.

Authors:  Suru Yue; Shasha Li; Xueying Huang; Jie Liu; Xuefei Hou; Yumei Zhao; Dongdong Niu; Yufeng Wang; Wenkai Tan; Jiayuan Wu
Journal:  J Transl Med       Date:  2022-05-13       Impact factor: 8.440

3.  Urinary immune cell phenotype of severe AKI in critically ill patients.

Authors:  Sílvia Coelho; Maria Guadalupe Cabral; Rute Salvador; Cláudia Andrade; Ana Martins; Bruna Correia; Paulo Freitas; Josep Maria Cruzado; António Jacinto
Journal:  Int Urol Nephrol       Date:  2022-01-23       Impact factor: 2.266

4.  3-deazaneplanocin A protects against cisplatin-induced renal tubular cell apoptosis and acute kidney injury by restoration of E-cadherin expression.

Authors:  Jun Ni; Xiying Hou; Xueqiao Wang; Yinfeng Shi; Liuqing Xu; Xiaoqing Zheng; Na Liu; Andong Qiu; Shougang Zhuang
Journal:  Cell Death Dis       Date:  2019-05-01       Impact factor: 8.469

5.  Neferine Attenuates Acute Kidney Injury by Inhibiting NF-κB Signaling and Upregulating Klotho Expression.

Authors:  Huihui Li; Wenhang Chen; Yusa Chen; Qiaoling Zhou; Ping Xiao; Rong Tang; Jing Xue
Journal:  Front Pharmacol       Date:  2019-10-15       Impact factor: 5.810

6.  Formononetin protects against cisplatin‑induced acute kidney injury through activation of the PPARα/Nrf2/HO‑1/NQO1 pathway.

Authors:  Yan Hao; Jie Miao; Wenjia Liu; Li Peng; Yue Chen; Qing Zhong
Journal:  Int J Mol Med       Date:  2020-12-01       Impact factor: 4.101

7.  Construction and Validation of a Risk Prediction Model for Acute Kidney Injury in Patients Suffering from Septic Shock.

Authors:  Suru Yue; Shasha Li; Xueying Huang; Jie Liu; Xuefei Hou; Yufeng Wang; Jiayuan Wu
Journal:  Dis Markers       Date:  2022-01-06       Impact factor: 3.434

8.  Severe acute kidney injury predicting model based on transcontinental databases: a single-centre prospective study.

Authors:  Qiqiang Liang; Yongfeng Xu; Yu Zhou; Xinyi Chen; Juan Chen; Man Huang
Journal:  BMJ Open       Date:  2022-03-03       Impact factor: 2.692

9.  Effect of anti-C5 antibody on recuperation from ischemia/reperfusion-induced acute kidney injury.

Authors:  Shani Zilberman-Itskovich; Ramzia Abu-Hamad; Moshe Stark; Shai Efrati
Journal:  Ren Fail       Date:  2019-11       Impact factor: 2.606

Review 10.  Klotho and Mesenchymal Stem Cells: A Review on Cell and Gene Therapy for Chronic Kidney Disease and Acute Kidney Disease.

Authors:  Marcella Liciani Franco; Stephany Beyerstedt; Érika Bevilaqua Rangel
Journal:  Pharmaceutics       Date:  2021-12-21       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.